Skip to content
10-Q

Quarterly Report

Prevail Therapeutics Inc.

0001564590-20-053728

← back to feed
Filed
Nov 13, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Nov 9, 2020 34.25M sh
Capex Q3 2020 · Sep 30, 2020 $544K
Capex Q3 2020 · Sep 30, 2019 $2.05M
Operating Cash Flow Q3 2020 · Sep 30, 2020 −$53.24M
Operating Cash Flow Q3 2020 · Sep 30, 2019 −$40.96M
Short Term Investments Q3 2020 · Sep 30, 2020 $9.76M
Short Term Investments Q3 2020 · Dec 31, 2019 $0
Cash And Equivalents Q3 2020 · Sep 30, 2020 $81.73M
Cash And Equivalents Q3 2020 · Dec 31, 2019 $168.05M
Cash And Equivalents Q3 2020 · Sep 30, 2019 $183.07M
Stockholders Equity Q3 2020 · Sep 30, 2020 $112.58M
Stockholders Equity Q3 2020 · Jun 30, 2020 $128.66M
Stockholders Equity Q3 2020 · Dec 31, 2019 $165.34M
Stockholders Equity Q3 2020 · Sep 30, 2019 $182.03M
Stockholders Equity Q3 2020 · Jun 30, 2019 $201.04M
Stockholders Equity Q3 2020 · Dec 31, 2018 −$18.42M
Current Liabilities Q3 2020 · Sep 30, 2020 $12.75M
Current Liabilities Q3 2020 · Dec 31, 2019 $11.83M
Total Liabilities Q3 2020 · Sep 30, 2020 $21.54M
Total Liabilities Q3 2020 · Dec 31, 2019 $21.76M
Current Assets Q3 2020 · Sep 30, 2020 $96.33M
Current Assets Q3 2020 · Dec 31, 2019 $174.46M
Total Assets Q3 2020 · Sep 30, 2020 $134.12M
Total Assets Q3 2020 · Dec 31, 2019 $187.1M
Sga Expense Q3 2020 · Sep 30, 2020 $6.3M
Sga Expense Q3 2020 · Sep 30, 2020 $23.37M
Sga Expense Q3 2020 · Sep 30, 2019 $4.45M
Sga Expense Q3 2020 · Sep 30, 2019 $10.05M
Rd Expense Q3 2020 · Sep 30, 2020 $12.32M
Rd Expense Q3 2020 · Sep 30, 2020 $36.68M
Rd Expense Q3 2020 · Sep 30, 2019 $16.84M
Rd Expense Q3 2020 · Sep 30, 2019 $37.2M
Net Income Q3 2020 · Sep 30, 2020 −$18.59M
Net Income Q3 2020 · Sep 30, 2020 −$59.26M
Net Income Q3 2020 · Sep 30, 2019 −$20.3M
Net Income Q3 2020 · Sep 30, 2019 −$45.35M
Operating Income Q3 2020 · Sep 30, 2020 −$18.62M
Operating Income Q3 2020 · Sep 30, 2020 −$60.05M
Operating Income Q3 2020 · Sep 30, 2019 −$21.29M
Operating Income Q3 2020 · Sep 30, 2019 −$47.25M